U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101161101161VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus InfectionCompletedHas ResultsGenotype 1 Chronic Hepatitis C|Treatment NaiveDrug: Ribavirin|Drug: Telaprevir|Drug: Pegylated interferon alfa-2a|Drug: Telaprevirhttps://ClinicalTrials.gov/show/NCT01241760
101162101162Exercise for Women With Peripheral Arterial DiseaseRecruitingNo Results AvailablePeripheral Artery Disease|Claudication|WomenBehavioral: Walking Exercise|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT01241747
101163101163Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCLActive, not recruitingNo Results AvailableDiffuse Large B-cell Lymphoma.Drug: Revlimidhttps://ClinicalTrials.gov/show/NCT01241734
101164101164Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Breast Cancer SurgeryDevice: Positron Emission Mammography (PEM)https://ClinicalTrials.gov/show/NCT01241721
101165101165Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple MyelomaRecruitingNo Results AvailableMultiple Myeloma|Auto Stem Cell TransplantDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT01241708
101166101166Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic PatientsCompletedNo Results AvailableDiabetesDietary Supplement: Oral nutritional supplement, food for special medical purposes|Dietary Supplement: Oral nutritional supplement, food for special medical purposeshttps://ClinicalTrials.gov/show/NCT01241695
101167101167Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant MesotheliomaCompletedNo Results AvailableMalignant (Pleural) MesotheliomaBiological: DC + CTXhttps://ClinicalTrials.gov/show/NCT01241682
101168101168Randomized, Placebo-controlled Study to Evaluate Effects of E5555 on Renal Function Parameters and OCT2 ActivityCompletedNo Results AvailableHealthy SubjectsDrug: E5555|Drug: E5555https://ClinicalTrials.gov/show/NCT01241669
101169101169Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1CompletedNo Results AvailableHealthy Men Age 50 Who Are Considering PSA ScreeningBehavioral: DESI for home viewing|Behavioral: DESI for viewing at Shared Medical Appointment|Behavioral: Option of SMA and DESI or DESI onlyhttps://ClinicalTrials.gov/show/NCT01241656
101170101170Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-respondersTerminatedNo Results AvailableHIVDrug: CYT107https://ClinicalTrials.gov/show/NCT01241643
101171101171Somato-sensory Reflex Arch in Spinal Cord Injury - Effect on Clinical OutcomeCompletedNo Results AvailableSpinal Cord InjuryProcedure: Somatosensory reflex arch (Xiao Procedure)https://ClinicalTrials.gov/show/NCT01241630
101172101172ENDO GIA Stapler With Duet Tissue Reinforcement System (TRS) Used in Pulmonary ResectionsTerminatedNo Results AvailableLung DiseaseDevice: Duet TRS|Device: Endo GIAhttps://ClinicalTrials.gov/show/NCT01241617
101173101173[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01241604
101174101174A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedHas ResultsPsoriasisDrug: CP 690,550 5 mg|Drug: CP 690,550 10 mg|Biological: Etanercept 50 mg|Other: Placebohttps://ClinicalTrials.gov/show/NCT01241591
101175101175Improving Behavioral Weight Loss Via Electronic Handheld DeviceCompletedNo Results AvailableObesityBehavioral: Lifestyle Counselinghttps://ClinicalTrials.gov/show/NCT01241578
101176101176ENDO GIAâ„¢ Stapler With ENDO GIAâ„¢ Reload With Tri-Stapleâ„¢ Technology in a Pulmonary ResectionCompletedHas ResultsLung CancerDevice: ENDO GIAâ„¢ Stapler with TRI-STAPLEâ„¢ Technologyhttps://ClinicalTrials.gov/show/NCT01241565
101177101177A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)CompletedNo Results AvailableClostridium Difficile InfectionBiological: MK-3415|Biological: MK-6072|Biological: MK-3415A|Biological: Placebo|Drug: SOChttps://ClinicalTrials.gov/show/NCT01241552
101178101178Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During HaemodialysisCompletedHas ResultsCardiovascular Diseases|Kidney Failure, ChronicDrug: Dabigatran etexilate|Drug: Dabigatran etexilate|Drug: Dabigatran etexilatehttps://ClinicalTrials.gov/show/NCT01241539
101179101179The COPD Patient Management European Trial (COMET)Active, not recruitingNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Other: Disease Management|Other: Usual site managementhttps://ClinicalTrials.gov/show/NCT01241526
101180101180Induced Changes in Ventilatory Responsiveness and Altitude ExposureCompletedNo Results AvailableAltitude|Hypoxia|Ventilation|Oxygen SaturationDrug: N Acetyl-Cysteinehttps://ClinicalTrials.gov/show/NCT01241513
101181101181Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess BlastsActive, not recruitingNo Results AvailableMyelodysplastic Syndromes|MDS|RAEB|Chronic Myelomonocytic LeukemiaDrug: ON 01910.Nahttps://ClinicalTrials.gov/show/NCT01241500
101182101182A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCompletedNo Results AvailablePrimary HypertensionDrug: valsartan/amlodipinehttps://ClinicalTrials.gov/show/NCT01241487
101183101183Effect of Fish Oil on Insulin SensitivityCompletedNo Results AvailableMetabolic Syndrome X|Type 2 Diabetes Mellitus|SarcopeniaDietary Supplement: EPAX 6000 (marine omega 3 EPA/DHA fatty acid concentrates|Dietary Supplement: Maize (corn) oilhttps://ClinicalTrials.gov/show/NCT01241474
101184101184A Study of LY2584702 in Solid TumorsCompletedNo Results AvailableCancerDrug: LY2584702https://ClinicalTrials.gov/show/NCT01241461
101185101185A Study of LY2409021 in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: LY2409021|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01241448
101186101186A Study of LY2216684 in Subjects With Impaired Hepatic FunctionCompletedNo Results AvailableDepressive Disorder, MajorDrug: LY2216684https://ClinicalTrials.gov/show/NCT01241435
101187101187A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge ModelCompletedNo Results AvailableAsthmaDrug: JNJ 40929837|Drug: Placebo|Drug: Montelukasthttps://ClinicalTrials.gov/show/NCT01241422
101188101188A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: Rabeprazole sodium: Treatment A|Drug: Rabeprazole sodium: Treatment B|Drug: Rabeprazole sodium: Treatment Chttps://ClinicalTrials.gov/show/NCT01241409
101189101189A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any ProcedureCompletedNo Results AvailableMultiple MyelomaOther: Any MMY treatmenthttps://ClinicalTrials.gov/show/NCT01241396
101190101190Effect of Bosentan in Scleroderma Renal CrisisActive, not recruitingNo Results AvailableScleroderma Renal CrisisDrug: Bosentanhttps://ClinicalTrials.gov/show/NCT01241383

* Görseller ve İçerik tekif hakkına sahip olabilir